New diabetes clinical trial: METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)
Published on: 2026-07-13T04:00:00Z Conditions : Type 1 Diabetes (T1D); Metabolic Diseases; Glucose Metabolism Disorders; Endocrine System Diseases; Autoimmune Diseases; Immune System Diseases; Diabetes Melletus, Type 1; Nutritional and Metabolic Diseases; Combination Therapy Interventions : Drug: AMX0035; Drug: Placebo Sponsors : University of Washington; Breakthrough T1D Recruiting https://ift.tt/rIWZLXR